Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 36

    1.

    Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.

    Thoenes M, Neuberger HR, Volpe M, Khan BV, Kirch W, Böhm M.

    J Hum Hypertens. 2009 Oct 1. [Epub ahead of print]PMID: 19798089 [PubMed - as supplied by publisher]Related articles

    2.

    Metabolic syndrome and cardiovascular disease in South Asians.

    Eapen D, Kalra GL, Merchant N, Arora A, Khan BV.

    Vasc Health Risk Manag. 2009;5:731-43. Epub 2009 Sep 7.PMID: 19756165 [PubMed - in process]Related articlesFree article

    3.

    Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.

    LeLeiko RM, Vaccari CS, Sola S, Merchant N, Nagamia SH, Thoenes M, Khan BV.

    Am J Cardiol. 2009 Sep 1;104(5):638-43. Epub 2009 Jun 24.PMID: 19699337 [PubMed - indexed for MEDLINE]Related articles

    4.

    Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.

    Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, Böhm M.

    Vasc Health Risk Manag. 2009;5(4):577-85. Epub 2009 Jul 14.PMID: 19649308 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Management of the statin-intolerant patient.

    Smiley III WH, Khan BV, Sperling LS.

    Curr Treat Options Cardiovasc Med. 2009 Aug;11(4):263-71.PMID: 19627659 [PubMed]Related articles

    6.

    Targeting multiple dyslipidemias with fixed combinations--focus on extended release niacin and simvastatin.

    Pandian A, Arora A, Sperling LS, Khan BV.

    Vasc Health Risk Manag. 2008;4(5):1001-9. Review.PMID: 19183748 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis.

    Vaccari CS, Lerakis S, Hammoud R, Khan BV.

    Am J Med Sci. 2008 Sep;336(3):270-7. Review.PMID: 18794623 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure.

    Pullen PR, Nagamia SH, Mehta PK, Thompson WR, Benardot D, Hammoud R, Parrott JM, Sola S, Khan BV.

    J Card Fail. 2008 Jun;14(5):407-13. Epub 2008 May 27.PMID: 18514933 [PubMed - indexed for MEDLINE]Related articles

    9.

    Investigations of statins in heart failure: inflammatory biomarkers and hormones.

    Khan BV, Rajagopalan S.

    Heart Fail Clin. 2008 Apr;4(2):171-6.PMID: 18433697 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of angiotensin-converting enzyme inhibitor therapy on levels of inflammatory markers in response to exercise-induced stress: studies in the metabolic syndrome.

    Vaccari CS, Rahman ST, Khan QA, Cheema FA, Khan BV.

    J Cardiometab Syndr. 2008 Winter;3(1):12-7.PMID: 18326980 [PubMed - indexed for MEDLINE]Related articles

    11.

    Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature.

    Hammoud RA, Vaccari CS, Nagamia SH, Khan BV.

    Vasc Health Risk Manag. 2007;3(6):937-45. Review.PMID: 18200812 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.

    Thoenes M, Oguchi A, Nagamia S, Vaccari CS, Hammoud R, Umpierrez GE, Khan BV.

    Int J Clin Pract. 2007 Nov;61(11):1942-8.PMID: 17935553 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome.

    Nagamia S, Pandian A, Cheema F, Natarajan R, Khan QA, Patel AD, Merchant N, Sola S, Khan BV.

    Prev Cardiol. 2007 Fall;10(4):204-9.PMID: 17917517 [PubMed - indexed for MEDLINE]Related articles

    14.

    Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease.

    Thoenes M, Bramlage P, Khan BV, Schieffer B, Kirch W, Weir MR.

    Future Cardiol. 2007 Sep;3(5):519-24.PMID: 19804307 [PubMed - in process]

    15.

    Letter by Hammoud et al regarding article "Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition".

    Hammoud R, Vaccari CS, Khan BV.

    Circulation. 2007 Jun 19;115(24):e637; author reply e638. No abstract available. PMID: 17576877 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Potential role of statin therapy in heart failure, atrial fibrillation and aortic stenosis.

    Nagamia S, Thoenes M, Khan QA, Pandian A, Khan BV.

    Future Cardiol. 2006 Nov;2(6):687-93.PMID: 19804261 [PubMed - in process]

    17.

    The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis.

    Yeh ET, Khan BV.

    J Thromb Haemost. 2006 Nov;4(11):2308-16. Epub 2006 Sep 8. Review.PMID: 16961584 [PubMed - indexed for MEDLINE]Related articles

    18.

    Atorvastatin: beyond lipid-lowering effects in the diabetic population.

    Ramos J, Khan QA, Thoenes M, Khan BV.

    Future Cardiol. 2006 Sep;2(5):527-33.PMID: 19804188 [PubMed - in process]

    19.

    Cocaine use in an urban medical population and the development of angiographically significant coronary artery disease.

    Patel AD, Sola S, Caneer P, Cheema FA, Gupta D, Helmy T, Khan BV.

    Prev Cardiol. 2006 Summer;9(3):144-7.PMID: 16849877 [PubMed - indexed for MEDLINE]Related articles

    20.

    Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.

    Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV.

    J Am Coll Cardiol. 2006 Jan 17;47(2):332-7. Epub 2005 Dec 20.PMID: 16412856 [PubMed - indexed for MEDLINE]Related articles

    21.

    Evidence-based management of acute myocardial infarction in the elderly--current perspectives.

    Wenger NK, Helmy T, Khan BV, Patel AD.

    MedGenMed. 2005 Mar 30;7(1):73. Review.PMID: 16369378 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.

    Sola S, Mir MQ, Rajagopalan S, Helmy T, Tandon N, Khan BV.

    J Card Fail. 2005 Oct;11(8):607-12.PMID: 16230264 [PubMed - indexed for MEDLINE]Related articles

    23.

    Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study.

    Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV.

    Circulation. 2005 Jan 25;111(3):343-8. Epub 2005 Jan 17.PMID: 15655130 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group.

    Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, Biasucci LM, Catravas JD, Cole TG, Cooper GR, Khan BV, Kimberly MM, Stein EA, Taubert KA, Warnick GR, Waymack PP; CDC; AHA.

    Circulation. 2004 Dec 21;110(25):e545-9. No abstract available. PMID: 15611379 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome.

    Khan BV, Sola S, Lauten WB, Natarajan R, Hooper WC, Menon RG, Lerakis S, Helmy T.

    Diabetes Care. 2004 Jul;27(7):1712-5.PMID: 15220251 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.

    Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP.

    Circulation. 2003 May 27;107(20):2601-6. Epub 2003 May 5.PMID: 12732602 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.

    Lauten WB, Khan QA, Rajagopalan S, Lerakis S, Rahman ST, Parthasarathy S, Khan BV.

    Am J Cardiol. 2003 May 1;91(9):1116-9. No abstract available. PMID: 12714159 [PubMed - indexed for MEDLINE]Related articles

    28.

    Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).

    Rahman ST, Lauten WB, Khan QA, Navalkar S, Parthasarathy S, Khan BV.

    Am J Cardiol. 2002 Mar 15;89(6):686-90.PMID: 11897210 [PubMed - indexed for MEDLINE]Related articles

    29.

    Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease.

    Khan BV, Navalkar S, Khan QA, Rahman ST, Parthasarathy S.

    J Am Coll Cardiol. 2001 Nov 15;38(6):1662-7.PMID: 11704378 [PubMed - indexed for MEDLINE]Related articles

    30.

    Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells.

    Natarajan R, Reddy MA, Malik KU, Fatima S, Khan BV.

    Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1408-13.PMID: 11557664 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Did the antioxidant trials fail to validate the oxidation hypothesis?

    Parthasarathy S, Khan-Merchant N, Penumetcha M, Khan BV, Santanam N.

    Curr Atheroscler Rep. 2001 Sep;3(5):392-8. Review.PMID: 11487450 [PubMed - indexed for MEDLINE]Related articles

    32.

    Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.

    Navalkar S, Parthasarathy S, Santanam N, Khan BV.

    J Am Coll Cardiol. 2001 Feb;37(2):440-4.PMID: 11216960 [PubMed - indexed for MEDLINE]Related articles

    33.

    Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.

    Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R.

    Diabetes. 1999 Apr;48(4):855-64.PMID: 10102704 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells.

    Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM.

    Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9114-9.PMID: 8799163 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells.

    Khan BV, Parthasarathy SS, Alexander RW, Medford RM.

    J Clin Invest. 1995 Mar;95(3):1262-70.PMID: 7533787 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies.

    Khan BV, Fungwe TV, Wilcox HG, Heimberg M.

    Biochim Biophys Acta. 1990 Jun 14;1044(3):297-304.PMID: 2364096 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...